Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
スポンサーリンク
概要
- 論文の詳細を見る
- 2010-12-15
著者
-
TOBINAI Kensei
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
OGURA Michinori
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
KAGAMI Yoshitoyo
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
ITOH Kuniaki
Division of Oncology and Hematology, National Cancer Center Hospital East
-
HOTTA Tomomitsu
Department of Hematology and Oncology, Tokai University School of Medicine
-
Tobinai K
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
Katayama Y
Division Of Hematology Saitama Medical Center Jichi Medical University
-
KINOSHITA Tomohiro
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
NAKAMURA Shigeo
Department of Clinical Pathology, Aichi Cancer Center Hospital
-
CHOU Takaaki
Department of Internal Medicine, Niigata Cancer Center Hospital
-
SHIMOYAMA Masanori
National Cancer Center Hospital
-
Nakamura S
Department Of Pathology Nagoya University School Of Medicine
-
Nakamura Shigeo
国立がんセンター中央病院 血液内科
-
Nakamura Shigeo
群馬県立がんセンター 病理検査
-
Kishimoto Yuji
The First Department Of Internal Medicine Kansai Medical University
-
Maeda S
Center For Hematopoietic Disorders Ohta Nishinouchi Hospital The Ohta Foundation
-
Seto M
Department Of Hematology And Chemotherapy
-
Seto Masao
愛知県がんセンター研究所 分子腫瘍学部
-
Seto Masao
東京大学医学部附属病院 無菌治療部
-
OHTSU Tomoko
Amgen Limited
-
OHTSU Tomoko
Division of Oncology/Hematology, Department of Medicine, National Cancer Center Hospital East
-
Kato T
Department Of Gastroenterological Surgery Aichi Cancer Center Hospital
-
Nakagawa Shun-ichi
鈴鹿中央総合病院(厚生連)
-
Kagami Y
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Tsuchiya S
Department Of Pediatrics Tohoku University School Of Medicine
-
Takeuchi T
Cancer Screening Division Research Center For Cancer Prevention And Screening National Cancer Center
-
Takeuchi Takahiro
愛知県立がんセンター病院
-
Sasaki Takeshi
Department Of Infection Control And Laboratory Diagnostics Tohoku University Graduate School Of Medi
-
Kobayashi Y
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
TAKENAKA Takeaki
Hematology Division, National Cancer Center Hospital
-
Takayama K
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Tsukasaki Kunihiro
Department Of Internal Medicine Osaka Medical Center For Cancer And Cardiovascular Diseases
-
Takeyama Kunihiko
東海大学 医学部
-
Hotta Tomomitsu
National Hospital Organization Nagoya Medical Center
-
Hotta Tomomitsu
国立がんセンター中央病院 血液内科
-
Hotta Tomomitsu
東海大学 医学研究科血液腫瘍内科
-
Chou Takaaki
東海大学 医学部
-
Chou Takaaki
Department Of Internal Medicine Niigata Cancer Center Hospital
-
Chou Takaaki
中華人民共和国
-
Tanimoto Kazuki
国立がんセンター中央病院
-
Terauchi Takashi
国立がんセンター中央病院 血液内科
-
Itoh K
Division Of Oncology And Hematology National Cancer Center Hospital East
-
Itoh Kuniaki
神戸大学 医学研究科腫瘍内科学
-
Itoh K
Department Of Chemistry Faculty Of Science Kobe University
-
Kagami Yoshitoyo
東海大学 医学部血液･腫瘍内科
-
Kagami Yoshitoyo
名古屋大学医学部附属病院 病理部
-
Kagami Yoshitoyo
東京大学医科学研究所ヒトゲノム解析センター
-
Miyawaki S
Division Of Hematology Tokyo Metropolitan Ohtsuka Hospital
-
Miyawaki Shuichi
Leukemia Research Center Saiseikai Maebashi Hospital
-
Ohnishi K
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Ohnishi Kazunori
東北大学病院 血液･免疫科
-
Ichimura Koichi
Department Of Hematology And Rheumatology Tohoku University Graduate School Of Medicine
-
Ishizawa Kenichi
東北大学 血液･免疫病学分野
-
Ishizawa K
Department Of Rheumatology And Hematology
-
Ishizawa Kenichi
Department Of Rheumatology And Hematology Tohoku University School Of Medicine
-
Ishizawa Kenichi
国立がんセンター東病院
-
TAKEYAMA Kunihiko
National Cancer Center Hospital
-
CHOU Takaaki
Niigata Cancer Center Hospital
-
OGITA Masami
Sapporo National Hospital
-
FUKUDA Haruhiko
JCOG Data Center, National Cancer Center
-
Yamamoto Kazuhito
Department Of Hematology And Cell Therapy Aichi Cancer Center Hospital
-
Yamamoto Kazuhito
愛知県がんセンター中央病院 血液･細胞療法部
-
Sawa Masashi
Department Of Molecular Medicine And Hematology Nagoya University Graduate School Of Medicine
-
Kanakura Yuzuru
大阪大学 医学系研究科心臓血管外科
-
Minami H
Department Of Hematology Fujita Health University School Of Medicine
-
Higashihara Masaaki
北里大学 医学部第4内科(血液内科)
-
Asaoku Hideki
山口大学 医学系研究科生体シグナル解析医学
-
Asaoku Hideki
Clinical Laboratory Hiroshima Red Cross Hospital Atomic-bomb Survivors Hospital
-
Asaoku Hideki
Department Of Clinical Laboratory Hiroshima Red Cross Hospital And Atomic-bomb Survivors Hospital
-
Asaoku Hideki
Hiroshima Red-cross Hospital
-
Hamaguchi Motohiro
東北大学病院 血液･免疫科
-
Tsubaki K
Kinki Univ. School Of Medicine Osaka Jpn
-
Tsubaki Kazuo
Third Department Of Internal Medicine Kinki University School Of Medicine
-
Tsubaki Kazuo
浜松医科大学 第3内科
-
Tsubaki Kazuo
近畿大学 産婦人科
-
Kamiya Yoshikazu
Department Of Hematology Meitetsu Hospital
-
Kamiya Yoshikazu
愛知がんセンター 血液･細胞療法部
-
Hotta T
National Hospital Organization Nagoya Medical Center
-
Hotta Tomomitsu
Department Of Hematology Molecular Medicine Unit Atomic Disease Institute Nagasaki University Gradua
-
Hata Tomoko
Nagasaki University
-
Hata Tomoko
Department Of Hematology Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki University G
-
Mukai Hirofumi
国立がんセンター東病院 化学療法科血液
-
SAI Toshiaki
Departments of Internal Medicine Iwaki-Kyoritsu General Hospital
-
SANO Masayuki
Departments of Internal Medicine Saga Medical School
-
MIKUNI Chikara
Departments of Internal Medicine Sapporo National Hospital
-
Kawase Yoshiaki
Department Of Internal Medicine Japanese Red Cross Nagoya First Hospital
-
Sakai Mari
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Odagiri Keiichi
Department Of Medicine Hamamatsu Red Cross Hospital
-
SASAKI Tsuneo
Department of Chemotherapy, Tokyo Metropolitan Kamagome Hospital
-
Sasaki Takeshi
Department Of Chemotherapy Tokyo Metropolitan Komagome Hospital
-
OKAMOTO Masataka
Department of Internal Medicine, Fujita Health University School of Medicine
-
Kuroishi T
Division Of Epidemiology And Cancer Prevention Aichi Cancer Center Research Institute
-
Kuroishi Tetsuo
愛知県がんセンター研究所
-
Nakamura Shigeo
名古屋大学 医学系研究科血液･腫瘍内科学
-
Nakamura Shigeo
Department Of Pathology Nagoya University School Of Medicine
-
Takeuchi Takahiro
Cancer Screening Division Research Center For Cancer Prevention And Screening National Cancer Center
-
Takahashi Toshitada
愛知県がんセンター研究所 腫瘍免疫学
-
Sato M
Division Of Molecular Medicine Aichi Cancer Center Research Institute
-
Sano Masayuki
Niigata Cancer Center Hospital
-
Hirano Masami
Department Of Internal Medicine Division Of Hematology And Medical Oncology Fujita Health University
-
Ishizawa Kenichi
Department Of Hematology And Rheumatology Tohoku University Graduate School Of Medicine
-
Itoh Kuniaki
Division Of Oncology And Hematology National Cancer Center Hospital East
-
Itoh Kuniaki
Hematology And Oncology Division National Cancer Center Hospital East
-
Itoh Kuniaki
Department Of Chemistry Faculty Of Science Kobe University
-
Kawase Ichiro
大阪大学 医学系研究科機能診断科学
-
Nakamura Shigeo
Department Of Pathology Nagoya University Graduate School Of Medicine
-
IKEDA Shuichi
Department of Medicine, City of Sasebo General Hospital,
-
Kuroishi Tetsuo
Division Of Epidemiology And Prevention Aichi Cancer Center Research Institute Aichi Cancer Center H
-
NASU Kaori
Osaka Red Cross Hospital
-
Shamoto M
Fujita Health Univ. Toyoake Jpn
-
Minami S
Nagasaki Cml Study Group
-
Minami S
(tottori University) United Graduate School Yamaguchi University
-
Ohshima Koichi
First Department Of Pathology Fukuoka University
-
Ohshima Koichi
First Department Of Pathology Fukuoka University School Of Medicine
-
Tobinai K
National Cancer Center Hospital Tokyo Jpn
-
Tobinai Kensei
Hematology And Stem Cell Transplantation Division National Cancer Center Hospital
-
Ichimura Koichi
Department Of Pathology Okayama University Graduate School Of Medicine Dentistry And Pharmaceutical
-
Mukai Hirofumi
National Cancer Center Hospital East Oncology/hematology
-
Matsuda Shin
Center For Hematopoietic Disorders Ohta Nishinouchi Hospital The Ohta Foundation
-
Kobayashi Yukio
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
OHNO Hitoshi
Department of Hematology, Takeda General Hospital
-
Tsukasaki K
Department Of Internal Medicine Osaka Medical Center For Cancer And Cardiovascular Diseases
-
Tsukasaki Kunihiro
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Ohno Hitoshi
Department Of Hematology And Oncology Graduate School Of Medicine Kyoto University
-
Oshimi Kazuo
Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Miyawaki Shuichi
Saiseikai Maebashi Hospital Maebashi Jpn
-
Chou T
Department Of Internal Medicine Niigata Cancer Center Hospital
-
Hirano Masami
Department Of Hematology Fujita Health University School Of Medicine
-
Hotta Tomomitsu
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Takatsuki K
Kumamoto Univ. School Of Medicine Kumamoto Jpn
-
Hata Tomoko
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Akiyama H
Tokyo Metropolitan Komagome Hospital Tokyo Jpn
-
Akiyama Hideki
Department Of Hematology Tokyo Metropolitan Komagome Hospital
-
Akiyama Hideki
Department Of Civil And Ocean Engineering Faculty Of Engineering Ehime University
-
Ikegame K
Division Of Hematology Department Of Internal Medicine Hyogo College Of Medicine
-
Ikegame Kazuhiro
Division Of Hematology Department Of Internal Medicine Hyogo College Of Medicine
-
Ogura M
Department Of Hematology And Cell Therapy Aichi Cancer Center
-
Yamao Kenji
Department Of Gastroenterology Aichi Cancer Center Central Hospital
-
Katayama Yoshio
Division Of Hematology Saitama Medical Center Jichi Medical University
-
Kinoshita Tomohiro
Mie University
-
Kinoshita Tomohiro
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Kawase Takakazu
医学生物学研究所
-
Katayama Yoshio
Hematology/oncology Department Of Medicine Kobe University Graduate School Of Medicine
-
Tobinai Kensei
National Cancer Center Hospital
-
Tobinai Kensei
Department Of Pharmacotherapy National Cancer Institute
-
Takenaka T
National Cancer Center Hospital Tokyo Jpn
-
Takenaka Takeaki
Hematology Division National Cancer Center Hospital
-
Ohtsu Tomoko
Amgen Kk
-
Ichimura Koichi
Department Of Pathology Okayama University Graduate School Of Medicine And Dentistry
-
Shirai Masato
Department Of Gastroenterology Aichi Cancer Center Hospital
-
Terauchi Takashi
Diagnostic Radiology Divisions National Cancer Center Hospital
-
Ogura Michinori
Department Of Hematology And Cell Therapy Aichi Cancer Center
-
Ogura Michinori
Department Of Hematology And Chemotherapy Aichi Cancer Center Hospital
-
Ichimura Koichi
Department Of Pathology And Molecular Diagnostics Aichi Cancer Center
-
Kagami Yoshitoyo
Department Of Pathology School Of Medicine Kurume University
-
Takahashi Shinichiro
Department Of Chemotherapy Tokyo Metropolitan Komagome Hospital
-
Nakamura Shigeo
Department Of Pathology And Clinical Laboratories Nagoya University Hospital
-
Ichimura Kouichi
Department Of Pathology Okayama University Medical School And Graduate School Of Medicine Dentistry
-
Ohnishi Kazunori
The "lung Injury By Bortezomib" Joint Committee Of The Japanese Society Of Hematology And
-
Okamoto Masataka
Department Of Medicine Fujita-health University School Of Medicine
-
Kobayashi Yoshimi
Division Of Hematology And Oncology Department Of Medicine Akita University School Of Medicine
-
Hirano Masami
Kitasato University Hospital
-
Koshikawa Takashi
Aichi Prefectural College Of Nursing & Health
-
Nakamura S
Department Of Anatomic And Molecular Pathology Aichi Cancer Center Hospital
-
Fukuda Haruhiko
Clinical Trials And Practice Support Division Center For Cancer Control And Information Services Nat
-
Ohnishi Kazunori
Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Omachi Ken
Department Of Hematology And Oncology Tokai University School Of Medicine
-
Ochi Kensuke
Laboratory Of Molecular Medicine Human Genome Center Institute Of Medical Science University Of Toky
-
Itoh Kuniaki
Contributors Special Connittee On 'mechanism And Chemotherapy For Adult Refractory Leukemia&apo
-
Mitsuya Hiroaki
Department Of Hematology And Infectious Diseases Kumamoto University Graduate School Of Medical Scie
-
Ohhashi Kyoichi
Department Of Clinical Pharmacology And Therapeutics Hamamatsu University School Of Medicine
-
Okamoto Masataka
Department Of Hematology School Of Medicine Fujita Health University
-
Kinoshita Tomohiro
Department Of Hematology Nagoya University School Of Medicine
-
Takeyama K
National Cancer Center Hospital Tokyo Jpn
-
Tanimoto K
Hematology And Stem Cell Transplantation Division National Cancer Center Hospital
-
Kagami Yoshitoyo
Department Of Hematology And Cell Therapy Aichi Cancer Center
-
Sasaki Tsuneo
Department Of Chemotherapy Tokyo Metropolitan Kamagome Hospital
-
Kawai Yasukazu
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Katayama Yoshio
Second Department Of Internal Medicine Okayama University Medical School
-
Ohtsu Tomoko
Division Of Oncology/hematology National Cancer Center Hospital East
-
Fukuda Haruhiko
Jcog Data Center National Cancer Center
-
Odagiri Keiichi
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Itoh Kuniaki
Division Of Hematology Department Of Internal Medicine Hyogo College Of Medicine
-
Suzuki Takashiro
Department Of Chemotherapy Tokyo Metropolitan Komagome Hospital
-
Yano Kunio
県西部浜松医療センター
-
Kimura Yukihiko
First Department Of Internal Medicine Tokyo Medical College
-
Asaoku Hideki
Internal Medicine Hiroshima Red Cross Hospital
-
Moritaka S
Department Of Surgery Ii Nagoya City University Medical School
-
Hotta Tomomitsu
Nagoya Medical Center Nagoya Jpn
-
Ohnishi Kazunori
The Division Of Hematology Department Of Medicine Iii Hamamatsu University School Of Medicine
-
OHNISHI Kazunori
The 3rd Department of Internal Medicine, Hamamatsu University School of Medicine
-
NASU Kaori
Department of Hematology, Osaka Red Cross Hospital
-
OKABE Kenichi
Department of Hematology, Shikoku National Hospital
-
SHIMOYAMA Masanori
Hematology Division, National Cancer Center Hospital
-
Ohashi K
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Nasu Kaori
Department Of Hematology Osaka Red Cross Hospital
-
Ikeda Shuichi
Department Of Hematology Sasebo City General Hospital
-
Mikuni Chikara
Department Of Hematology Sapporo National Hospital
-
Sai T
Department Of Chemotherapy Tokyo Metropolitan Cancer And Infectious Diseases Center Komagome Hospita
-
Ogura Michinori
Department Of Hematology And Chemotherapy Aichi Cancer Center
-
Kimura Yoshizo
Department Of Pathology School Of Medicine Kurume University
-
Sai T
Department Of Chemotherapy Tokyo Metropolitan Cancer And Infectious Diseases Center Komagome Hospita
-
Okamoto Masataka
Department Of Internal Medicine Division Of Hematology And Medical Oncology Fujita Health University
-
Okabe Kenichi
Department Of Hematology Shikoku National Hospital
-
Ohno Hitoshi
Department Of Hematology And Oncology Clinical Sciences For Pathological Organs Graduate School Of M
-
Okamoto Masataka
Department Of Internal Medicine Division Of Hematology And Medical Oncology Fujita Health University
-
Nakamura Satoko
Department Of Pathology Okayama University Graduate School Of Medicine Dentistry And Pharmaceutical
-
Tsukasaki Kunihiro
The Department Of Haematology Of Atomic Disease Institute Nagasaki University School Of Medicine
-
Ohnishi Kazunori
Shikoku National Hospital Matsuyama Jpn
-
Okabe Kenichi
Department Of Cell Pathology Graduate School Of Medical Sciences Kumamoto University
-
Nakamura Shigeo
Department Of Cardiovascular Diseases. Kokura National Hospital
-
Nakamura Shigeo
Department Of Pathology Nagoya University
-
Ichimura Koichi
Department Of Pathology Okayama University Medical School And Graduate School Of Medicine Dentistry
-
Mikuni Chikara
Department Of Hematology Hokkaido Cancer Center
-
Amano Hiroki
Department Of Public Health Shimane University Faculty Of Medicine
-
Fukuda Haruhiko
Jcog Data Center Center For Cancer Control And Information Services National Cancer Center
-
Mori Sayaka
Department Of Clinical Laboratory Nagasaki University Hospital
-
Itoh Kuniaki
Division of Hematology and Oncology, National Cancer Center Hospital East
-
Ohtsu Tomoko
Division of Hematology and Oncology, National Cancer Center Hospital East
-
KINOSHITA Tomohiro
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
NAKAMURA Shigeo
Department of Applied Chemistry, Faculty of Engineering, Kanagawa University
-
OKAMOTO Masataka
Department of Hematology and Medical Oncology, Fujita Health University School of Medicine
関連論文
- Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan : a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group
- Accumulation of common polymorphisms is associated with development of hypertension : a 12-year follow-up from the Ohasama study
- Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy
- Progressive multifocal leukoencephalopathy in a patient with B-cell lymphoma during rituximab-containing chemotherapy : case report and review of the literature
- Stromal cells in bone marrow play important roles in pro-inflammatory cytokine secretion causing fever following bortezomib administration in patients with multiple myeloma
- Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma : morphological, immunohistochemical, and FISH analyses
- Nocardia exalbida brain abscess in a patient with follicular lymphoma
- Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
- Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy
- Promoter Hypermethylation of the DNA-Repair Gene O^6-Methylguanine-DNA Methyltransferase and p53 Mutation in Diffuse Large B-Cell Lymphoma
- Loss of O^6-Methylguanine-DNA Methyltransferase Protein Expression Is a Favorable Prognostic Marker in Diffuse Large B-Cell Lymphoma
- Quantification of molecules in ^1H-NMR metabolomics with formate as a concentration standard
- Standardized Prevalence Ratios for Chronic Hepatitis C Virus Infection Among Adult Japanese Hemodialysis Patients
- In vivo Retrovirus-mediated Herpes Simplex Virus Thymidine Kinase Gene Therapy Approach for Adult T Cell Leukemia in a Rat Model
- Serum Levels of Soluble Fas/APO-1 Receptor in Human Retroviral Infection and Associated Diseases
- Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Dietary Risk Factors for Colon and Rectal Cancers : A Comparative Case-Control Study
- Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
- Plasma B-Type Natriuretic Peptide Level and Cardiovascular Events in Chronic Kidney Disease in a Community-Based Population
- Phase I Study of Intravenous PSC-833 and Doxorubicin: Reversal of Multidrug Resistance
- Factors Influencing Participation Rate in a Baseline Survey of a Genetic Cohort in Japan
- Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma
- Phase I study of radioimmunotherapy with an anti-CD20 murine radioimmunoconjugate (^Y-ibritumomab tiuxetan) in relapsed or refractory indolent B-cell lymphoma
- Durable Response but Prolonged Cytopenia after Cladribine Treatment in Relapsed Patients with Indolent non-Hodgkin's Lymphomas : Results of a Japanese Phase II Study
- t(11 ; 18)-Bearing Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma Responding to Cladribine
- Two Entities of Precursor T-Cell Lymphoblastic Leukemia/Lymphoma Based on Radiologic and Immunophenotypic Findings
- Primary Mediastinal Large B-Cell Lymphoma : A Single-Institution Clinical Study in Japan
- EBV-Positive Burkitt Lymphoma as a Late-Onset Posttransplantion Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation
- Primary Hepatic Low-Grade B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue Type : A Case Report and Review of the Literature
- Successful Allogeneic Bone Marrow Transplantation in a Case of Adult Precursor B-Lymphoblastic Lymphoma
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Unrelated-Donor Bone Marrow Transplantation with a Conditioning Regimen Including Fludarabine, Busulfan, and 4 Gy Total Body Irradiation
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- Prediction of Sensitivity to STI571 among Chronic Myeloid Leukemia Patients by Genome-wide cDNA Microarray Analysis
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Evaluation of organ involvement in intravascular large B-cell lymphoma by ^F-fluorodeoxyglucose positron emission tomography
- Sustained Remission after Rituximab-containing Chemotherapy for Intravascular Large B-cell Lymphoma
- Epigenetic Regulation of CD20 Protein Expression in a Novel B-Cell Lymphoma Cell Line, RRBL1, Established from a Patient Treated Repeatedly with Rituximab-Containing Chemotherapy
- Phase I Trial of FLAGM with High Doses of Cytosine Arabinoside for Relapsed, Refractory Acute Myeloid Leukemia : Study of the Japan Adult Leukemia Study Group (JALSG)
- Phase III study to evaluate the use of high-dose chemotherapy as consolidation of treatment for high-risk postoperative breast cancer : Japan Clinical Oncology Group study, JCOG 9208
- Phase II Study of Cladribine(2-Chlorodeoxyadenosine) in Relapsed or Refractory Adult T-Cell Leukemia-Lymphoma
- Phase III Study of Ranimustine, Cyclophosphamide, Vincristine, Melphalan, and Prednisolone (MCNU-COP/MP) versus Modified COP/MP in Multiple Myeloma : A Japan Clinical Oncology Group Study, JCOG 9301
- Imatinib Provides Durable Molecular and Cytogenetic Responses in a Practical Setting for Both Newly Diagnosed and Previously Treated Chronic Myelogenous Leukemia : A Study in Nagasaki Prefecture, Japan
- Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma
- Primary Hepatic Follicular Lymphoma : A Case Report and Discussion of Chemotherapy and Favorable Outcomes
- Randomized phase II study of concurrent and sequential rituximab and CHOP chemotherapy in untreated indolent B-cell lymphoma
- Senile Epstein-Barr Virus-Associated B-Cell Lymphoproliferative Disorders : a Mini Review
- Polymorphism of dihydropyrimidine dehydrogenase (DPYD) Cys29Arg and risk of six malignancies in Japanese
- CD56/NCAM-Positive Langerhans Cell Sarcoma : A Clinicopathologic Study of 4 Cases
- Phenotypic analysis of peripheral T/NK cell lymphoma : Study of 408 Japanese cases with special reference to their anatomical sites
- Pilot Phase I/II Study of New Salvage Therapy(CHASE) for Refractory or Relapsed Malignant Lymphoma
- Efficacy and Safety of Imatinib Mesylate for Patients in the First Chronic Phase of Chronic Myeloid Leukemia : Results of a Japanese Phase II Clinical Study
- Central nervous system involvement in intravascular large B-cell lymphoma : A retrospective analysis of 109 patients
- Morphological spectrum of cyclin D1-positive mantle cell lymphoma : Study of 168 cases
- Peripheral T/Natural Killer - Cell Lymphoma Involving the Female Genital Tract: A Clinicopathologic Study of 5 Cases
- Systemic Mastocytosis with Extensive Polypoid Lesions in the Intestines; Successful Treatment with Interferon-α
- Iron Intake and Associated Factors in General Japanese Population : NIPPON DATA80, NIPPON DATA90 and National Nutrition Monitoring
- Population pharmacokinetics of docetaxel in patients with hepatic dysfunction treated in an oncology practice
- Pharmacokinetics and pharmacodynamics of protein-unbound docetaxel in cancer patients
- Extragonadal germ cell tumors in Japan
- Treatable Subsets in Cancer of Unknown Primary Origin
- Toxicity and efficacy of ifosfamide, carboplatin and etoposide (modified ICE) as a salvage chemotherapy in Japanese patients with relapsed or refractory aggressive non-Hodgkin's lymphoma
- Recurrent Breast Cancer Treated Successfully with Mitomycin-C and Vinblastine after Failure of Both Doxorubicin-containing Regimen and Paclitaxel : A Case Report
- A Limited Sampling Model for Estimating Pharmacokinetics of CPT-11 and Its Metabolite SN-38
- Pharmacological Correlation between Total Drug Concentration and Lactones of CPT-11 and SN-38 in Patients Treated with CPT-11
- 1P345 NMRメタボロミクスの医療への応用 : 透析患者血漿と廃液の解析(その他,第48回日本生物物理学会年会)
- CHANGES IN ACTIVITIES OF DAILY LIVING,PHYSICAL FITNESS, AND DEPRESSIVE SYMPTOMS AFTER SIX-MONTH PERIODIC WELL-ROUNDED EXERCISE PROGRAMS FOR OLDER ADULTS LIVING IN NURSING HOMES OR SPECIAL NURSING FACILITIES
- CD34^+-Selected Autologous Peripheral Blood Stem Cell Transplantation Conditioned With Total Body Irradiation for Malignant Lymphoma: Increased Risk of Infectious Complications
- Assessment of Prognostic Factors in Follicular Lymphoma Patients
- A high dose chemoradiotherapy and peripheral blood stem cell support combined with the CD34^+-selection method in cyclin D1^+-mantle cell lymphoma
- Somatic Hypermutations in the V_H Segment of Immunoglobulin Genes of CD5-positive Diffuse Large B-Cell Lymphomas
- Pulmonary non-caseating granuloma in Waldenstrom macroglobulinemia
- Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
- NAD(P)H : quinone oxidoreductase 1 (NQ01) C609T polymorphism and the risk of eight cancers for Japanese
- Re-Treatment of Relapsed Indolent B-Cell Lymphoma With Rituximab
- Cytotoxic large T-cell lymphoma with fulminant clinical course,CD8^+ and CD56^-phenotype, and its relation to Epstein-Barr virus:a report of two cases
- Clinicopathologic study of nasal T/NK-cell lymphoma among the Japanese
- Hematopoietic stem cell transplantation for therapy-related myelodysplastic syndrome and acute leukemia : a single-center analysis of 47 patients
- Clinical Effects of Infusing Anti-Epstein -Barr Virus (EBV)-Specific Cytotoxic T-Lymphocytes into Patients with Severe Chronic Active EBV Infection
- Comparison of Soluble and Membrane Bound HLA-Class I and DR Levels in Umbilical Cord Blood and Adult Peripheral Blood
- The Generation of Immunocompetent Dendritic Cells From CD34^+ Acute Myeloid or Lymphoid Leukemia Cells
- Autografting with peripheral blood CD34-positive cells following high-dose chemotherapy against breast cancer
- Growth Inhibition of CD20-positive B Lymphoma Cell Lines by IDEC-C2B8 Anti-CD20 Monoclonal Antibody
- Development of novel humanized anti-CD20 antibodies based on affinity constant and epitope
- Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma
- Feasibility of salvage chemotherapy for refractory or relapsed non-Hodgkin's lymphoma with two topoisomerase II inhibitors, MST-16 and VP-16
- Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- Treatment of Indolent Non-Hodgkin's Lymphoma with Cladribine as Single-Agent Therapy and in Combination with Mitoxantrone
- Proteasome inhibitor, bortezomib, for myeloma and lymphoma
- Current treatment strategy and new agents in mantle cell lymphoma
- Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
- Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with
- Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
- Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma : 7-year follow-up results
- Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I study of inotuzumab ozogamicin (CMC-544) in Japanese patients with follicular lymphoma pretreated with rituximab-based therapy
- Review of primary unknown cancer : cases referred to the National Cancer Center Hospital East